LICITRA, LISA FRANCESCA LINDA
LICITRA, LISA FRANCESCA LINDA
Dipartimento di Oncologia ed Emato-Oncologia
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2026 D. Rischin, A. R Hansen, E.E. W Cohen, M. Tahara, K. J Harrington, R. I Haddad, L. Licitra, H. Mehanna, R. L Ferris, P. Koralewski
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study
2025 J. Bourhis, L. Licitra, B. Burtness, A. Psyrri, R. Haddad, K. Harrington, E.E.W. Cohen, J.D. Schoenfeld
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal canonccer
2025 M. Ferrari, F. Mularoni, D. Smussi, P. Gaudioso, P. Bonomo, J. Friborg, M.G. Ghi, V. Gregoire, K. Harrington, K. Hunter, R. Maroldi, R. Martino, R. Mesia, G. Peretti, A. Psyrri, A. Schindler, G. Succo, P. Szturz, I. Vilaseca, P. Nicolai, P. Bossi, J.P. Agarwal, M. Ansarin, A. Argiris, P. Balermpas, N.M.L. Battisti, E. Bellini, A. Bertolin, A.L.C. Carobbio, C.M. Chiesa-Estomba, B. Cirauqui, E. Crosetti, T.B. De Oliveira, A. Deganello, A. Dietz, J.G. Eriksen, A. Eskander, N. Fakhry, A. Falco, D. Farina, R. Ferrarotto, C. Franzese, S. Ghosh Laskar, W. Golusinski, E.Y. Hanna, J.C. Irish, N. Kiyota, L.P. Kowalski, S. Krishnan, N. Lee, C.R. Leemans, L. Licitra, L.D. Locati, J.-. Machiels, F. Marchi, D. Mattavelli, H. Mehanna, G. Mercante, N. Montalto, P. Morbini, B. O'Sullivan, M. Oliva, E. Orlandi, A. Paderno, V. Paleri, F. Pameijer, F. Perri, R. Persio, C. Piazza, Y. Pointreau, L. Presutti, M. Ravanelli, D. Rischin, J.P. Rodrigo, A. Ruaro, G. Sanguineti, C. Simon, L. Siu, A. Spreafico, G. Spriano, S. Taboni, U. Tassini, S. Tribius, M. Van Den Brekel, V. Vander Poorten, D. Viros Porcuna
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCC
2025 N.F. Saba, K. Harrington, L. Licitra, J.-. Machiels, C. He, T. Jew, V. Andrianov, R. Haddad
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials
2025 C. Gurizzan, M. Cinquini, L. Legramandi, C. Resteghini, M. Siano, C. Bergamini, L. Lorini, D. Smussi, A. Paderno, L. Licitra, P. Bossi
Sinonasal Sarcomas Management: An International Consensus Statement
2025 A. Vinciguerra, F. Caspani, M. Valentini, A.M. Camarda, S. Provenzano, E.W. Wang, C. Meco, M. Ferrari, P. Surda, S. Harrabi, F.A.B. Campos, J.M. Broto, B.A. Guadagnolo, P. Navarria, A. Hosni, N. Hindi, A. Italiano, D.M. Trifiletti, B. Kasper, B. Verillaud, A. Schreiber, P. Castelnuovo, P. Nicolai, I. Dallan, M. Chacon, S.Y. Su, J. Thariat, C. Valverde, M. Lechner, J.Y. Blay, M.R. Fiore, J.A. Eloy, M. Brahmi, J.N. Palmer, V.C. Oliden, D. Greto, I. Lugowska, A.P.D. Tos, T. Van Zele, A.J. Psaltis, P.G. Casali, A. Dufresne, C. Sangalli, C. Georgalas, E. Orlandi, P.-. Wormald, P. Herman, R. Carrau, E.Y. Hanna, L. Licitra, M. Turri-Zanoni, P. Battaglia
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma
2025 A. Corti, D. Lenoci, V.D.A. Corino, D. Mattavelli, M. Ravanelli, T. Poli, S. Cavalieri, L. Licitra, L. De Cecco, L. Mainardi
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma
2025 J.-. Machiels, Y. Tao, L. Licitra, B. Burtness, M. Tahara, D. Rischin, G.V. Alves, I.P.F. Lima, B.G.M. Hughes, Y. Pointreau, S. Aksoy, S. Laban, R. Greil, M. Burian, M. Hetnal, J.-. Delord, R. Mesia, M. Taberna, J. Waldron, C. Simon, V. Gregoire, K. Harrington, C.M. Black, J.M. Norquist, A. Wang, B. Gumuscu, B. Bidadiand, L.L. Siu
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck
2025 P. Szturz, T. Fuereder, Y. Guo, L. Licitra, R. Mesia, P. Ivanyi, A. Falco, M. Tahara, M.-. Solbes, F. Venturini, P. Bossi
Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma
2025 D. Lenoci, M.S. Serafini, M. Lucchetta, S. Cavalieri, R.H. Brakenhoff, F. Hoebers, K. Scheckenbach, T. Poli, L. Licitra, L. De Cecco
Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
2025 C. Resteghini, B. Baujat, P. Bossi, A. Franchi, L. De Gabory, J. Halamkova, F. Haubner, J.A.U. Hardillo, M.A. Hermsen, N.A. Iacovelli, R. Maroldi, S. Mattheis, A. Moya-Plana, P. Nicolai, E. Orlandi, J. Thariat, A. Trama, M.W.M. Van Den Brekel, C.M.L. Van Herpen, B. Verillaud, E. Kinloch, L. Licitra, C. Even
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
2025 R. Galot, C. Le Tourneau, L. Licitra, J. Guigay, A. Kong, I. Tinhofer, C. Even, A. Daste, S. Henry, C. Borel, C. Abdeddaim, E. Seront, J.B. Prevost, A. Rutten, E. Saada-Bouzid, F. Rolland, P. Bonomo, M. Rasschaert, L. Dirix, C. Olungu, K. Tsechilidou, A.S. Govaerts, C. Fortpied, A. Joaquim, J.P. Machiels
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
2025 E. Colombo, S. Cavalieri, A. Vingiani, L. Agnelli, M. Duca, B. Paolini, F. Perrone, E. Tamborini, I. Capone, A. Piccolo, F. Caspani, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, A. Ottini, S. Buriolla, M. Salvetti, G. Calareso, M. Milione, G. Pruneri, L.D. Locati, L. Licitra
Gender Diversity in the Middle Management Matters: Examining Gender Metrics for Organizational and Sustainable Success
2025 A.D. Chiaramonte, C. Marazzi, D. Terruzzin, L. Anemoni, A. Mereghetti, E. Orlandi, L. Licitra
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2025 J. Fayette, L. Licitra, K. Harrington, R. Haddad, L.L. Siu, Y.-. Liu, M. Tahara, J.-. Machiels, D. Rischin, T.Y. Seiwert, R.L. Ferris, U. Keilholz, A. Psyrri, B. Keam, P. Bossi, R. Metcalf, C.-. Hsieh, P.M.J. Clement, P. Isaev, A. Mudunov, J. Dinis, A. Hoeben, S. Kasper, K. Klinghammer, M. Hwang, J. Blando, O. Serrano, D. Ruscica, R.B. Cohen
Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial
2025 M.C. Merlano, N. Denaro, M. Paccagnella, A. Abbona, D. Galizia, S. Alfieri, C. Bergamini, E. Orlandi, A.M. Merlotti, S. Bondi, L. Licitra, O. Garrone
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer
2025 C. Even, K.J. Harrington, E. Massarelli, S. Laban, J. Fayette, M. Oliva, M. Klein Hesselink, S. Visscher, M.G. Fury, A.-. Wiekmeijer, L. Licitra, B. Melichar, L.A. Devriese, I. Brana, P. Jankowska, M. Posner, B. Glisson, A. Kong, L. Hooftman, C.J.M. Melief, R. Ferrarotto
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes
2025 P. Mccoon, Y. Wang, Z. Lai, Q. Zhang, W. Li, S. Wildsmith, N. Morsli, R. Raja, N. Holoweckyj, J. Walker, M. De Los Reyes, R. Mesia, L. Licitra, R.L. Ferris, J. Fayette, D.P. Zandberg, L.L. Siu, R. Haddad
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study
2025 A. Desilets, J. Lucas, L.F. Licitra, S. Lu, A. Tse, T. Tang, K. Dreyer, N. He, L.E. Birgerson, S. Faivre, D. Soulières
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial
2025 P. Bossi, A. Alberti, C. Bergamini, C. Resteghini, L.D. Locati, S. Alfieri, S. Cavalieri, E. Colombo, C. Gurizzan, L. Lorini, V. Tovazzi, M. Zamparini, M. Ravanelli, P.A. Ascierto, V. Rampinelli, A. Grammatica, R. Patuzzo, A. Maurichi, L.F. Licitra